Table 2 Malaria outcomes per camp
Adezai | Baghicha | Jalala | Kagan | Zangal Patai | ||||||
|---|---|---|---|---|---|---|---|---|---|---|
% | 95 % CI | % | 95 % CI | % | 95 % CI | % | 95 % CI | % | 95 % CI | |
P. vivax | ||||||||||
SCR | 0.016 | 0.013–0.020 | 0.036 | 0.031–0.043 | 0.063 | 0.054–0.073 | 0.029 | 0.025–0.035 | 0.017 | 0.014–0.021 |
Seroprevalence | 17.6 | 14.2–20.9 | 32.5 | 28.4–36.6 | 47.5 | 43.1–51.9 | 28.9 | 24.9–32.9 | 19.1 | 15.7–22.6 |
PCR | 7.0 | 3.7–11.7 | 9.1 | 4.4–13.9 | 15.6 | 12.5–18.6 | 3.7 | 0–6.2 | 6.9 | 2.8–10.6 |
RDT | 0.4 | 0–0.9 | 2.8 | 1.3–4.2 | 9.7 | 7.1–12.3 | 2.0 | 0.8–3.2 | 4.1 | 2.4–5.9 |
P. falciparum | ||||||||||
SCR | 0.002 | 0.002–0.004 | 0.007 | 0.005–0.009 | 0.003 | 0.002–0.005 | 0.002 | 0.001–0.003 | 0.008 | 0.006–0.011 |
Seroprevalence | 3.2 | 1.6–4.7 | 9.1 | 6.6–11.6 | 4.5 | 2.7–6.4 | 2.4 | 1.1–3.8 | 9.9 | 7.2–12.5 |
PCR | 0 | 0 | 1.4 | 0.6–2.6 | 0.8 | 0–2.3 | 0 | |||
RDT | 0 | 0 | 0 | 0 | 0.2 | 0–0.6 | ||||